Company intelligence / Profile preview

Acerus Pharmaceuticals

Mississauga, Ontario, Canadaaceruspharma.in ↗
Ownership
Public · ASP
Employees
~14
Development stage
Other
01

Overview

Acerus has commercialized Natesto®—a bioadhesive intranasal testosterone gel for male hypogonadism—and Estrace®, an oral plant-derived estradiol therapy for menopausal symptoms. Gynoflor® offers ultra-low dose vaginal estrogen therapy. Noctiva™—a vasopressin analog nasal spray—is approved in the US for nocturia. Tefina®, a low-dose nasal testosterone gel for female sexual dysfunction and Lidbree™, a short acting lidocaine formulation delivered intravaginally are in development. The company’s pipeline also includes combination therapies targeting benign prostatic hyperplasia and overactive bladder[1][3][6][8].

Therapeutic areas
NephrologyMen's HealthWomen's Health
Modalities
Small moleculeHormoneDevicePeptides
Industry
Biotech
02

Partnerships

Syneos Health – contract commercial provider in the United States[8]Amneal Pharmaceuticals – co-promotion agreement signed May 2021[9]Aytu BioScience – previous co-promotion partner on Natesto[9]

Beyond the preview

Go deeper on Acerus Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Acerus Pharmaceuticals.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call